Ferring Pharmaceuticals. “With AI-powered technology, we can now identify skills gaps in real-time, enabling employees to seek out growth opportunities while helping managers connect with the right ...

The promotional effort from Ferring features bladder cancer survivors sharing the news of a new treatment option.

diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile infection (C. diff) in individuals 18 years of age and older ...

Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) ‎announces the appointment of. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while ...

Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Male Fertility Market Report 2025" has been added to ResearchAndMarkets.com's offering. This report covers market characteristics, size and growth, ...

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.” - The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /EINPresswire ...

Tonight will be a dry and calm night with extensively clear skies and little to no cloud around throughout. The odd mist or fog patch may develop locally during the early hours. Monday Tomorrow ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

C. diff causes nearly 30,000 deaths each year in the US, says Ferring, and recurrent infections with the bacterium make up 10%-15% of all hospital-treated infections.

Adstiladrin, on the other hand, has struggled with supply issues, though Ferring says availability has recently improved. HC Wainwright projects 2025 Anktiva revenue of $137.4 million, growing to ...